Oaktree Acquisition Corp... Quote - OACB

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

9.38

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

9.38

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Alvotech und Oaktree Acquisition Corp. II melden Zustimmung der Aktionäre zum Unternehmenszusammenschluss

Zusammenschluss soll voraussichtlich am bzw. um den 15. Juni 2022 abgeschlossen werden Stammaktien von Alvotech sollen ab 16. Juni 2022 am...

Alvotech et Oaktree Acquisition Corp. II annoncent l'approbation des actionnaires pour le regroupement d'entreprises

Le regroupement d'entreprises devrait être finalisé (vers) le 15 juin 2022 Les actions ordinaires d'Alvotech devraient être négociées sous le...

Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination

Business Combination anticipated to close on or about June 15, 2022 Ordinary shares of Alvotech expected to trade under the new ticker symbol...

Oaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotech

Business Combination remains subject to satisfaction of customary closing conditions, including shareholder approval Oaktree Acquisition Corp...

Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®

The confirmatory clinical, safety and efficacy study for AVT04, biosimilar candidate to Stelara® (ustekinumab) met its primary endpoint AVT04...

Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®

- Results from pharmacokinetic (PK) similarity study demonstrate bioequivalence of AVT04 (ustekinumab) to the reference product...

Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination

Alvotech Holdings S.A. (“Alvotech S.A.”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

OACB - Frequently Asked Questions (FAQ)

What is the current Oaktree Acquisition Corp... share price?

The current share price of Oaktree Acquisition Corp... is US$ 9.38

What is the 1 year trading range for Oaktree Acquisition Corp... share price?

Oaktree Acquisition Corp... has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUSNu Skin Enterprises Inc	US$ 7.55 (17.60%)	3.59M
PCORProcore Technologies Inc	US$ 87.50 (16.51%)	4.58M
LANVLanvin Group Holdings Limited	US$ 1.85 (16.35%)	64.01k
ZHZhihu Inc	US$ 5.31 (15.43%)	4.06M
CAECae Inc	US$ 26.8085 (14.03%)	1.85M
GWHESS Tech Inc	US$ 4.01 (-26.96%)	330.85k
INFAInformatica Inc	US$ 19.75 (-21.53%)	27.95M
SASeabridge Gold Inc	US$ 11.28 (-15.38%)	3.54M
TWLOTwilio Inc	US$ 125.17 (-15.01%)	15.5M
HLHecla Mining Company	US$ 5.42 (-14.91%)	33.12M
BBAIBigBear ai Holdings Inc	US$ 9.015 (-7.82%)	84.26M
NIONIO Inc	US$ 4.43 (3.99%)	54.3M
FFord Motor Company	US$ 9.4701 (1.28%)	53.78M
BABAAlibaba Group Holding Limited	US$ 124.73 (4.34%)	52.74M
QBTSD Wave Quantum Inc	US$ 6.37 (-2.00%)	52.14M

02opida 4 minutes ago

LVRO

02opida 4 minutes ago

ZION

02opida 5 minutes ago

BBAI

02opida 5 minutes ago

AAGH

02opida 5 minutes ago

BEP

02opida 5 minutes ago

SHEL

02opida 5 minutes ago

VCIGF

Trinityz1 5 minutes ago

VIDEO: At Least Three Killed in Kentucky as Flooding Hits Four States

just checking if you're ok.........

https://www.breitbart.com/weather/2025/02/16/video-at-least-three-killed-in-kentucky-as-flooding-hits-four-states/

02opida 5 minutes ago

GWAV

bbotcs 5 minutes ago

p_s_h: Don't get it. I don't mind looking stupid! EOM

02opida 5 minutes ago

MPAA

zab 6 minutes ago

Once again, where is Melania Trump, since January 24, 2025, she has avoided being with Donald at the Superbowl, and countless Republican events.

02opida 6 minutes ago

PIFYF

JoshTaeger 6 minutes ago

Means nothing other than Alex has time on his hands, given that NoRide is dead in the water, looking for someone to buy it for its LOIs.

NRDE

02opida 6 minutes ago

TRUX

02opida 6 minutes ago

VCIGF

02opida 6 minutes ago

BORR

02opida 6 minutes ago

UHAL

joe botts 6 minutes ago

Well no truer words! Revoked forever

02opida 7 minutes ago

AILE

02opida 7 minutes ago

BPOP

02opida 7 minutes ago

DNMR

02opida 7 minutes ago

CVII

bbotcs 7 minutes ago

Seminole Red: The mockingbird should be the national symbol. Eagles HATE people.
But they ARE majestic. Great picture.

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Oaktree Acquisition Corp II (OACB)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Ask ADVFN Intelligence (AI)

OACB Latest News

Alvotech und Oaktree Acquisition Corp. II melden Zustimmung der Aktionäre zum Unternehmenszusammenschluss

Alvotech et Oaktree Acquisition Corp. II annoncent l'approbation des actionnaires pour le regroupement d'entreprises

Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination

Oaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotech

Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®

Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®

Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination

Alvotech améliore son accès aux capitaux et optimise son processus d’entrée en bourse, prévue sur le NASDAQ

Alvotech verbessert Zugang zu Kapital und ebnet Weg für erwartete NASDAQ-Notierung

Alvotech migliora l'accesso al capitale e semplifica il percorso verso la prevista quotazione in Borsa al NASDAQ

OACB - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Oaktree Acquisition Corp II (OACB) Share Price

Oaktree Acquisition Corp II (OACB)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Ask ADVFN Intelligence (AI)

OACB Latest News

Alvotech und Oaktree Acquisition Corp. II melden Zustimmung der Aktionäre zum Unternehmenszusammenschluss

Alvotech et Oaktree Acquisition Corp. II annoncent l'approbation des actionnaires pour le regroupement d'entreprises

Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination

Oaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotech

Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®

Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®

Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination

Alvotech améliore son accès aux capitaux et optimise son processus d’entrée en bourse, prévue sur le NASDAQ

Alvotech verbessert Zugang zu Kapital und ebnet Weg für erwartete NASDAQ-Notierung

Alvotech migliora l'accesso al capitale e semplifica il percorso verso la prevista quotazione in Borsa al NASDAQ

OACB - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS